FDA Clearance Tracker · P180007-S011
Spiration Valve System
Last checked: Nov 20, 2026Latest source record: Sep 22, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Sep 22, 2023
Approved
Time to decision
29 days
Received Aug 24, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P180007-S011
- Device name
- Spiration Valve System
- Applicant
- Gyrus Acmi, Inc.
- Applicant location
- Redmond, WA
- Received
- Aug 24, 2023
- Decided
- Sep 22, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P180007
Device type
- Device type
- Valve, pulmonary (NJK)
- Device class
- Class III
- Specialty
- Anesthesiology & Respiratory
FDA's approval statement
As written in FDA's record.
Approval for the modification to the Informed Consent Template for the STRIVE Registry Study to permit payment to study participants for study visits.
Source documents
Other decisions for Gyrus Acmi, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252487 · Decided Mar 2, 2026 · 207 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.